Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | POLB | P06746 | 1/20 | 0.45 |
| ▸ | NPC1 | O15118 | 1/20 | 0.43 |
| ▸ | RAB9A | P51151 | 1/20 | 0.43 |
| ▸ | ATM | Q13315 | 1/20 | 0.43 |
| ▸ | GLA | P06280 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.30 |
| ▸ | HPGD | P15428 | 2/20 | 0.30 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.30 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.30 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.30 |
| ▸ | GAA | P10253 | 1/20 | 0.30 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.30 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.30 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Triforine SCHEMBL8064620 | 0.86 | ALDH1A1 (0.34) | POLBALDH1A1HPGDCYP2C19CYP1A2 | |
| Triforine SCHEMBL23278 | 0.86 | ALDH1A1 (0.34) | POLBALDH1A1HPGDCYP2C19CYP1A2 | |
| SCHEMBL7180786 | 0.81 | ALDH1A1 (0.44) | ALDH1A1HPGDCYP2C19CYP1A2MAPT | |
| Triforine SCHEMBL10335796 | 0.78 | POLB (0.31) | POLBALDH1A1HPGDCYP2C19CYP1A2 | |
| Triforine SCHEMBL11829811 | 0.78 | ALDH1A1 (0.39) | POLBNPC1RAB9AATMGLA | |
| SCHEMBL9652015 | 0.78 | POLB (0.31) | POLBALDH1A1HPGDCYP2C19CYP1A2 | |
| Hydrochloric Acid SCHEMBL10987504 | 0.76 | POLB (0.30) | POLB | |
| SCHEMBL13406758 | 0.74 | ALDH1A1 (0.31) | ALDH1A1MAPT | |
| Triforine SCHEMBL27822360 | 0.73 | ALDH1A1 (0.36) | POLBALDH1A1HPGDCYP2C19CYP1A2 | |
| SCHEMBL5565559 | 0.71 | SMN1; SMN2 (0.40) | NPC1RAB9AALDH1A1HPGDCYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 338 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2026105160-A1 | NOVEL AGROCHEMICAL COMPOSITION COMPRISING 3-SUBSTITUTED PHENYLAMIDINE COMPOUNDS AND USE THEREOF | PI INDUSTRIES LTD. (IN) | 2026-05-21 | — | — | WO | claimed |
| EP-4646108-A1 | TERNARY COMPOSITION COMPRISING 3-SUBSTITUTED PHENYLAMIDINE COMPOUNDS AND USE THEREOF | PI Industries Ltd. (IN) | 2025-11-12 | — | — | EP | claimed |
| US-20250302037-A1 | MULTICOMPONENT FUNGICIDES | ADAMA MAKHTESHIM LTD. (IL) | 2025-10-02 | — | — | US | claimed |
| US-20250089717-A1 | FUNGICIDAL HALOMETHYL KETONES, HYDRATES AND ENOL ETHERS AND THEIR MIXTURES | FMC CORP (US) | 2025-03-20 | — | — | US | claimed |
| EP-4521929-A1 | MULTICOMPONENT FUNGICIDES | ADAMA MAKHTESHIM LTD. (IL) | 2025-03-19 | — | — | EP | claimed |
| US-20240315243-A1 | A COMBINATION OF FLUBENDIAMIDE AND SEAWEED EXTRACT | PI INDUSTRIES LTD. (IN) | 2024-09-26 | — | — | US | claimed |
| WO-2024147155-A1 | TERNARY COMPOSITION COMPRISING 3-SUBSTITUTED PHENYLAMIDINE COMPOUNDS AND USE THEREOF | PI INDUSTRIES LTD. (IN) | 2024-07-11 | — | — | WO | claimed |
| EP-4361150-A2 | FUNGICIDAL OXADIAZOLES AND THEIR MIXTURES | FMC Corporation (US) | 2024-05-01 | — | — | EP | claimed |
| US-20240122180-A1 | FUNGICIDAL HALOMETHYL KETONES AND HYDRATES AND THEIR MIXTURES | FMC CORPORATION | 2024-04-18 | — | — | US | claimed |
| US-20240090503-A1 | FUNGICIDAL OXADIAZOLES AND THEIR MIXTURES | FMC CORPORATION | 2024-03-21 | — | — | US | claimed |
| WO-2022113033-A1 | AGROCHEMICAL COMPOSITION COMPRISING 3-SUBSTITUTED PHENYLAMIDINE COMPOUNDS AND USE THEREOF | PI INDUSTRIES LTD. (IN) | 2022-06-02 | — | — | WO | claimed |
| WO-2022099169-A1 | PREDICTIVE PESTICIDE RESISTANCE MAP GENERATION AND USE | PIONEER HI-BRED INTERNATIONAL, INC. (US) | 2022-05-12 | — | — | WO | claimed |
| CN-106417305-A | Fungicidal pyrazoles and their mixtures | 杜邦公司 | 2017-02-22 | — | — | CN | claimed |
| CN-106342817-A | Fungicidal pyrazole mixtures | 纳幕尔杜邦公司 | 2017-01-25 | — | — | CN | claimed |
| CN-103140136-B | fungicidal pyrazoles and mixtures thereof | DUPONT (US) | 2016-05-11 | — | — | CN | claimed |
| CN-104394693-A | Fungicidal pyrazole mixtures | DU PONT | 2015-03-04 | — | — | CN | claimed |
| CN-103188935-A | Penflufen as a wood preservative against xylophagous basidiomycetes | LANXESS DEUTSCHLAND GMBH | 2013-07-03 | — | — | CN | claimed |
| CN-103140136-A | Fungicidal pyrazoles and mixtures thereof | DU PONT | 2013-06-05 | — | — | CN | claimed |
| CN-101969781-A | Fungicidal compounds and mixtures | DU PONT | 2011-02-09 | — | — | CN | claimed |
| EP-0075613-B1 | PROCESS FOR THE PREPARATION OF N-(1-FORMYLAMIDO-2,2,2-TRICHLOROETHYL)-MORPHOLINE | BASF Aktiengesellschaft (DE) | 1985-06-12 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240315243-A1 | A COMBINATION OF FLUBENDIAMIDE AND SEAWEED EXTRACT | ACHE, DDT, ARF4 | POLB 3732/4885NPC1 4417/4885RAB9A 383/4885 |
| US-20240090503-A1 | FUNGICIDAL OXADIAZOLES AND THEIR MIXTURES | NOX1, TH, NOX3 | POLB 4254/4885NPC1 1651/4885RAB9A 1660/4885 |
| US-20240122180-A1 | FUNGICIDAL HALOMETHYL KETONES AND HYDRATES AND THEIR MIXTURES | AKR7A2, TBCA, TUBA1C | POLB 4612/4885NPC1 910/4885RAB9A 1150/4885 |
| US-20250089717-A1 | FUNGICIDAL HALOMETHYL KETONES, HYDRATES AND ENOL ETHERS AND THEIR MIXTURES | HCN2, CYP8B1, TUBA3C | POLB 4546/4885NPC1 484/4885RAB9A 1122/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.